
ALT A graph from the Original Article "Coronary CT Angiography versus Intravascular Ultrasound Guidance for PCI." The trial name, P4, is in parentheses after the title. The graph shows the cumulative incidence of target-vessel failure (primary end point), defined as a composite of death from cardiac causes, target-vessel myocardial infarction, or ischemia-driven target-vessel revascularization, at 12 months. The trial results are being presented at the Transcatheter Cardiovascular Therapeutics 2026 Conference. The logo of the New England Journal of Medicine is at the bottom.

ALT A illustration showing anticoagulation for atrial fibrillation with intermediate stroke risk. On the left, a medicine box labeled "Anticoagulant Tablets" with two pills is shown. In the center, a silhouette of a patient with a highlighted heart. Above, a round inset displays a heart rate monitor graph representing atrial fibrillation. To the right, a brain is depicted with an inset showing a blood vessel and a warning symbol, representing intermediate stroke risk.

ALT A figure from the Original Article "Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain." The trial name, TARGET-CTCA, is in parentheses after the title. The figure shows the incidence of myocardial infarction or death from a cardiac cause. The trial results are being presented at the European Society of Cardiology Congress 2026. The logo of the New England Journal of Medicine is at the bottom.









































